Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

July 2006 · Vol. 18, No. 7

SURGICAL TECHNIQUES

Things go better with Burch

CARE trial: Burch colposuspension at the time of prolapse surgery improves postop urinary control


Fast Track

“The research community is reaching a consensus that ‘subjective’ measures are more important than objective measures”
—Anne M. Weber, MD

“This study is not ‘finished.’ Our participants are in active follow-up for 2 years following surgery“
—Linda Brubaker, MD, MS

“Patients who are continent preoperatively, but become stress-incontinent postoperatively, are particularly unhappy”
—Mark D. Walters, MD

“Even when Burch colposuspension was performed, a number of women still had urinary incontinence after surgery”
—Anne M. Weber, MD

“Doing a Burch procedure at the time of sacrocolpopexy is a time-efficient and low-morbidity addition”
—Linda Brubaker, MD, MS

“I think mostwomen would be dissatisfied with a 44% risk of postoperative stress incontinence requiring a second surgery”
—Mark D. Walters, MD

“All clinicians providing care for women should routinely inquire about pelvic symptoms”
—Anne M. Weber, MD

“I am not aware of any legal precedent in which a clinical study or data provided solid protection from a jury verdict”
—Neeraj Kohli, MD, MBA

IN THIS ARTICLE

Why should we care about the CARE (Colpopexy and Urinary Reduction Efforts) trial?

Because pelvic organ prolapse and urinary incontinence are already major problems facing women as they age, and will become even more pervasive as the baby boomer generation moves through menopause and beyond.

Sign in now to read more...

Back to top


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement